New York Times Pushing for Lithium and Other Drugs in Water Supply – Alex Jones Tv 1/3
New York Times Pushing for Lithium and Other Drugs in Water Supply – Alex Jones Tv 1/3 – New York Times and Other Media Pushing for Drugging Water Supply Matt Ryan www.infowars.com August 2, 2010 Big Think, a website that interviews scientists and experts in various fields has begun a month-long series called, “Dangerous Ideas” and the first post features drugging the public water supply. The expert they interviewed for this story is Jacob M. Appel, a bioethicist and medical historian, who has written in favor of adding lithium to the public water supply. He states clearly that he believes lithium and other “enhancers” are beneficial additions to our public water supply and any opposition is based on false assumptions that natural water is better than artificially enhanced water. He expanded on this claim in his 2009 article featured in Huffington Post. In the article he cites a Japanese study claiming that lithium reduces suicides. Meanwhile, the New York Times has published a story admitting that drugs are currently in the public water supply. These drugs include Ibuprofen, Naproxen, anti-epileptic and anti-anxiety drugs. Earlier this week, Aaron Dykes wrote a detailed article in response to an Oxford professor calling for adding drugs to the water supply. www.infowars.com
New Documents on Activist Surveillance May Be "Just the Tip of the Iceberg"
Filed under: drug rehab treatment ny
Occupy Wall Street at Liberty Square in New York City, NY. … These documents show that the FBI and the Department of Homeland Security are treating protests against the corporate and banking structure of America as potential criminal and terrorist …
Read more on Truth-Out
Lorus Therapeutics Announces Successful Dose Escalation of Its Phase I …
Filed under: drug rehab treatment ny
The success of this study allows Lorus to initiate a biomarker clinical investigation to further explore the effects of the drug at relevant doses determined in the clinical trial. This Phase I clinical study program, conducted at Memorial Sloan …
Read more on Marketwire (press release)